Skip to main content
. Author manuscript; available in PMC: 2015 Aug 17.
Published in final edited form as: Ann Intern Med. 2015 Feb 17;162(4):266–275. doi: 10.7326/M14-1281

Appendix Table 1.

Intended Age Group, Predicted Outcome, and Variables Included Among Risk Scores Being Evaluated

Risk Score Reference Target Age Group, y Target Cardiovascular Events Variables
FRS-CHD 4 30–74 Angina, MI, death from CHD, and coronary insufficiency Age, total cholesterol level, HDL cholesterol level, BP, diabetes status, smoking status, and sex
FRS-CVD 11 30–74 Angina, MI, death from CHD, stroke, TIA, peripheral vascular disease, and heart failure Age, total cholesterol level, HDL cholesterol level, BP, diabetes status, smoking status, sex, and antihypertensive medication use
ATPIII-FRS-CHD 5 >20 MI and death from CHD Age, total cholesterol level, HDL cholesterol level, BP, smoking status, sex, and antihypertensive medication use
RRS 12, 22 Women: 45–80
Men: 50–80
MI, death from CHD, stroke, and coronary revascularization Age, total cholesterol level, HDL cholesterol level, BP, diabetes status, smoking status, sex, hs-CRP level, family history, and HbA1c level*
AHA-ACC-ASCVD 13 40–79 MI, death from CHD, and stroke Age, total cholesterol level, HDL cholesterol level, BP, diabetes status, smoking status, sex, white or African American ethnicity, and antihypertensive medication use

ACC = American College of Cardiology; AHA = American Heart Association; ASCVD = atherosclerotic cardiovascular disease; ATPIII = Adult Treatment Panel III; BP = blood pressure; CHD = coronary heart disease; CVD = cardiovascular disease; FRS = Framingham risk score; HbA1c = hemoglobin A1c; HDL = high-density lipoprotein; hs-CRP = high-sensitivity C-reactive protein; MI = myocardial infarction; RRS = Reynolds Risk Score; TIA = transient ischemic attack.

*

Female participants with diabetes only.

HHS Vulnerability Disclosure